APO RESEARCH · REPORT
Software as a Medical Device (SaMD)
SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.
Product & engineering
Understand the product.
SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.
Selected research
Market Analysis & Forecast
Global Software as a Medical Device (SaMD) Market Analysis and Forecast 2026-2032
Market perspective
SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.
According to types, the most proportion of the Global Software as a Medical Device market share is Cloud-based, taking about 67.34% share of global market in 2020. The most proportion of the Global Software as a Medical Device market share is used for Monitoring and Alerting and the proportion is about 41.55% in 2020.
Report Includes
Read the full market overview
This report presents an overview of global market for Software as a Medical Device (SaMD), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Software as a Medical Device (SaMD), also provides the revenue of main regions and countries. Of the upcoming market potential for Software as a Medical Device (SaMD), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Software as a Medical Device (SaMD) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Software as a Medical Device (SaMD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Software as a Medical Device (SaMD) revenue, projected growth trends, production technology, application and end-user industry.
Software as a Medical Device (SaMD) Segment by Company
MindMaze
Medtronic
Viz.AI.
Siemens Healthcare
iSchemaView
Arterys
Adherium
Digital Diagnostics
Allscripts
Software as a Medical Device (SaMD) Segment by Type
Cloud-based
On Premise
Software as a Medical Device (SaMD) Segment by Application
Screening and Diagnosis
Monitoring and Alerting
Chronic Disease Management
Other
Software as a Medical Device (SaMD) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Software as a Medical Device (SaMD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Software as a Medical Device (SaMD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Software as a Medical Device (SaMD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Software as a Medical Device (SaMD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Software as a Medical Device (SaMD) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Software as a Medical Device (SaMD) revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On Premise
Applications
- Screening and Diagnosis
- Monitoring and Alerting
- Chronic Disease Management
- Other
Companies covered
- MindMaze
- Medtronic
- Viz.AI.
- Siemens Healthcare
- iSchemaView
- Arterys
- Adherium
- Digital Diagnostics
- Allscripts
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Software as a Medical Device (SaMD) Market by Type
- 1.2.1 Global Software as a Medical Device (SaMD) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cloud-based
- 1.2.3 On Premise
- 1.3 Software as a Medical Device (SaMD) Market by Application
- 1.3.1 Global Software as a Medical Device (SaMD) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Screening and Diagnosis
- 1.3.3 Monitoring and Alerting
- 1.3.4 Chronic Disease Management
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Software as a Medical Device (SaMD) Market Dynamics
- 2.1 Software as a Medical Device (SaMD) Industry Trends
- 2.2 Software as a Medical Device (SaMD) Industry Drivers
- 2.3 Software as a Medical Device (SaMD) Industry Opportunities and Challenges
- 2.4 Software as a Medical Device (SaMD) Industry Restraints
3 Global Growth Perspective
- 3.1 Global Software as a Medical Device (SaMD) Market Perspective (2021-2032)
- 3.2 Global Software as a Medical Device (SaMD) Growth Trends by Region
- 3.2.1 Global Software as a Medical Device (SaMD) Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Software as a Medical Device (SaMD) Market Size by Region (2021-2026)
- 3.2.3 Global Software as a Medical Device (SaMD) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Software as a Medical Device (SaMD) Revenue by Players
- 4.1.1 Global Software as a Medical Device (SaMD) Revenue by Players (2021-2026)
- 4.1.2 Global Software as a Medical Device (SaMD) Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Software as a Medical Device (SaMD) Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Software as a Medical Device (SaMD) Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Software as a Medical Device (SaMD) Key Players Headquarters & Area Served
- 4.4 Global Software as a Medical Device (SaMD) Players, Product Type & Application
- 4.5 Global Software as a Medical Device (SaMD) Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Software as a Medical Device (SaMD) Market CR5 and HHI
- 4.6.3 2025 Software as a Medical Device (SaMD) Tier 1, Tier 2, and Tier 3
5 Software as a Medical Device (SaMD) Market Size by Type
- 5.1 Global Software as a Medical Device (SaMD) Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 5.3 Global Software as a Medical Device (SaMD) Revenue Market Share by Type (2021-2032)
6 Software as a Medical Device (SaMD) Market Size by Application
- 6.1 Global Software as a Medical Device (SaMD) Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 6.3 Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 MindMaze
- 7.1.1 MindMaze Company Information
- 7.1.2 MindMaze Business Overview
- 7.1.3 MindMaze Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.1.4 MindMaze Software as a Medical Device (SaMD) Product Portfolio
- 7.1.5 MindMaze Recent Developments
- 7.2 Medtronic
- 7.2.1 Medtronic Company Information
- 7.2.2 Medtronic Business Overview
- 7.2.3 Medtronic Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.2.4 Medtronic Software as a Medical Device (SaMD) Product Portfolio
- 7.2.5 Medtronic Recent Developments
- 7.3 Viz.AI.
- 7.3.1 Viz.AI. Company Information
- 7.3.2 Viz.AI. Business Overview
- 7.3.3 Viz.AI. Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.3.4 Viz.AI. Software as a Medical Device (SaMD) Product Portfolio
- 7.3.5 Viz.AI. Recent Developments
- 7.4 Siemens Healthcare
- 7.4.1 Siemens Healthcare Company Information
- 7.4.2 Siemens Healthcare Business Overview
- 7.4.3 Siemens Healthcare Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.4.4 Siemens Healthcare Software as a Medical Device (SaMD) Product Portfolio
- 7.4.5 Siemens Healthcare Recent Developments
- 7.5 iSchemaView
- 7.5.1 iSchemaView Company Information
- 7.5.2 iSchemaView Business Overview
- 7.5.3 iSchemaView Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.5.4 iSchemaView Software as a Medical Device (SaMD) Product Portfolio
- 7.5.5 iSchemaView Recent Developments
- 7.6 Arterys
- 7.6.1 Arterys Company Information
- 7.6.2 Arterys Business Overview
- 7.6.3 Arterys Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.6.4 Arterys Software as a Medical Device (SaMD) Product Portfolio
- 7.6.5 Arterys Recent Developments
- 7.7 Adherium
- 7.7.1 Adherium Company Information
- 7.7.2 Adherium Business Overview
- 7.7.3 Adherium Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.7.4 Adherium Software as a Medical Device (SaMD) Product Portfolio
- 7.7.5 Adherium Recent Developments
- 7.8 Digital Diagnostics
- 7.8.1 Digital Diagnostics Company Information
- 7.8.2 Digital Diagnostics Business Overview
- 7.8.3 Digital Diagnostics Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.8.4 Digital Diagnostics Software as a Medical Device (SaMD) Product Portfolio
- 7.8.5 Digital Diagnostics Recent Developments
- 7.9 Allscripts
- 7.9.1 Allscripts Company Information
- 7.9.2 Allscripts Business Overview
- 7.9.3 Allscripts Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
- 7.9.4 Allscripts Software as a Medical Device (SaMD) Product Portfolio
- 7.9.5 Allscripts Recent Developments
8 North America
- 8.1 North America Software as a Medical Device (SaMD) Revenue (2021-2032)
- 8.2 North America Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 8.2.1 North America Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
- 8.2.2 North America Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
- 8.3 North America Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
- 8.4 North America Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 8.4.1 North America Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
- 8.4.2 North America Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
- 8.5 North America Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
- 8.6 North America Software as a Medical Device (SaMD) Revenue by Country
- 8.6.1 North America Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
- 8.6.3 North America Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Software as a Medical Device (SaMD) Revenue (2021-2032)
- 9.2 Europe Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 9.2.1 Europe Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
- 9.2.2 Europe Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
- 9.3 Europe Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
- 9.4 Europe Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 9.4.1 Europe Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
- 9.4.2 Europe Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
- 9.5 Europe Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
- 9.6 Europe Software as a Medical Device (SaMD) Revenue by Country
- 9.6.1 Europe Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
- 9.6.3 Europe Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Software as a Medical Device (SaMD) Revenue (2021-2032)
- 10.2 China Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 10.2.1 China Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
- 10.2.2 China Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
- 10.3 China Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
- 10.4 China Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 10.4.1 China Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
- 10.4.2 China Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
- 10.5 China Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Software as a Medical Device (SaMD) Revenue (2021-2032)
- 11.2 Asia Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 11.2.1 Asia Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
- 11.2.2 Asia Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
- 11.3 Asia Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
- 11.4 Asia Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 11.4.1 Asia Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
- 11.4.2 Asia Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
- 11.5 Asia Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
- 11.6 Asia Software as a Medical Device (SaMD) Revenue by Country
- 11.6.1 Asia Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
- 11.6.3 Asia Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Software as a Medical Device (SaMD) Revenue (2021-2032)
- 12.2 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
- 12.2.1 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
- 12.2.2 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
- 12.3 SAMEA Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
- 12.4 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
- 12.4.1 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
- 12.4.2 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
- 12.5 SAMEA Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
- 12.6 SAMEA Software as a Medical Device (SaMD) Revenue by Country
- 12.6.1 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
- 12.6.3 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst